Scientists Identify Two Gene Variants Associated with Alzheimer's Risk – 2
Narrator: This is NIH Health Matters. A genome-wide association study is a research approach that involves rapidly scanning complete sets of DNA, or genomes, of many people. Researchers try to find genetic variations associated with a particular disease. Once new genetic associations are identified, researchers can use that information to develop better strategies to detect, treat and prevent the disease. In the largest genome-wide association study reported to date involving Alzheimer's disease, scientists have identified two new possible genetic risk factors for late-onset Alzheimer's disease.
Dr. Snyder: One gene was the clusterin gene.
Narrator: Dr. Steve Snyder is with the National Institute on Aging.
Dr. Snyder: The other gene was PICALM.
Narrator: This study involved more than 16,000 DNA samples. For details, visit www.nia.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.